Inequitable conduct

Last updated

In United States patent law, inequitable conduct is a breach of the applicant's duty of candor and good faith during patent prosecution or similar proceedings by misrepresenting or omitting material information with the specific intent to deceive the United States Patent and Trademark Office. A claim of inequitable conduct is a defense to allegations of patent infringement. Even in an instance when a valid patent suffers infringement, a court ruling on an allegation of infringement may exercise its power of equitable discretion not to enforce the patent if the patentee (the patent owner) has engaged in inequitable conduct.

Contents

Duty of candor

The U.S. Patent and Trademark Office's Rule 56 explains that patents are "affected with a public interest. The public interest is best served, and the most effective patent examination occurs when, at the time an application is being examined, the Office is aware of and evaluates the teachings of all information material to patentability." Accordingly, each individual person "associated with the filing and prosecution of a patent application has a duty of candor and good faith in dealing with the Office, which includes a duty to disclose to the Office all information known to that individual to be material to patentability." [1]

Specifics

Inequitable conduct occurs when a patent applicant misrepresents or omits material information with the specific intent to deceive the United States Patent and Trademark Office. In other words, the elements of inequitable conduct are materiality and deceptive intent. Deceptive intent may be inferred from indirect or circumstantial evidence but not from materiality.

Information is material if "the PTO would not have allowed a claim had it been aware of the undisclosed prior art" or if "affirmative egregious misconduct" has happened. See Therasense, Inc. v. Becton. [2] In response to Therasense, the USPTO rewrote its definition of materiality to say that information is material if

(1) It establishes, by itself or in combination with other information, a prima facie case of unpatentability of a claim; or
(2) It refutes, or is inconsistent with, a position the applicant takes in:
(i) Opposing an argument of unpatentability relied on by the Office, or
(ii) Asserting an argument of patentability. [1]

The misrepresentation or omission can include:

(a) failure to submit material prior art known by the applicant;
(b) failure to explain references in a foreign language or submit pre-existing full or partial translations of the references;
(c) misstatements of fact, including misstatements in affidavits concerning patentability; and
(d) mis-description of inventorship (authorship).

The party asking the court to decline to enforce the patent, usually the alleged infringer, bears the burden of proving inequitable conduct to the court. The moving party must show by clear and convincing evidence that the patentee intentionally withheld or misrepresented information, and that the information was material. [1] Proven inequitable conduct in any claim can expose the entire patent to unenforceability.

On appeal, a finding of inequitable conduct is reviewed under the standard of abuse of discretion. [3]

History

The unclean hands cases of Keystone Driller v. General Excavator, Hazel-Atlas v. Hartford, and Precision v. Automotive formed the basis for the doctrine of inequitable conduct that developed and evolved over time. [2]

Keystone case

In the 1933 Keystone case, the patentee manufactured and suppressed evidence in a patent application and its subsequent defense in two different infringement actions: the patentee paid the prior art user to perjure himself by signing a false affidavit that his use was an abandoned experiment, and bought the prior art user's agreement to keep secret the prior use details and to suppress that evidence. Unsurprisingly, the patentee also did not disclose those facts to the PTO or to co-litigants in the infringement actions. The defendants in the second action discovered and presented evidence of the malfeasance, and while the trial court refused dismissal on that ground, on appeal the Sixth Circuit reversed the trial court and remanded for dismissal, and the Supreme Court affirmed. [4]

Hazel-Atlas case

In the 1944 Hazel-Atlas case, a patentee's attorneys also manufactured and suppressed evidence in support of a patent application by hiring an expert to publish an article in a trade journal under his own name praising the invention as a remarkable advance in the art. After the patent was approved and issued on that basis, the patentee brought an infringement action against Hazel-Atlas but was unsuccessful in the trial court, so the patentee then appealed the matter to the Third Circuit where the patentee introduced the procured trade journal article. That appellate court reversed the trial court and ruled for the patentee, after which Hazel-Atlas settled on the infringement claim, and the patentee then paid the expert more money. The patentee's lies were discovered, however, in US v. Hartford-Empire, [5] whereupon Hazel-Atlas petitioned the Third Circuit to reconsider its prior decision, and although it refused, the Supreme Court didn't and reversed, vacating the appellate court's decision and the judgment against Hazel-Atlas, and reinstating the trial court's original judgment dismissing the patentee's case. [6]

Precision case

In the 1945 Precision case, the patentee suppressed evidence of perjury before the PTO and attempted to enforce the perjury-tainted patent. In the application to the PTO the patentee claimed false dates of conception, disclosure, drawing, description, and reduction to practice, and then testified to the veracity of the same lies in an interference proceeding. The competing patentee discovered the truth, but procured rights to the patent by private settlement, complicit in the scheme, and then sought to enforce the patent against others. In a later enforcement action, a trial court learned of the facts and ruled against the patentee based on the patentee having unclean hands, but the Seventh Circuit appellate court reversed, and on further appeal, the Supreme Court reversed, reinstating the trial court's decision. [7]

Landmark court cases

McKesson case

In the 2007 case McKesson v. Bridge Medical, [8] the Federal Circuit Court of Appeals found inequitable conduct because a patent attorney failed to provide to patent examiners information from an office action in a related case. McKesson is a cautionary tale for patent applicants: be overly inclusive with patent submissions to ensure no omission will jeopardize a patent. [9]

Exergen case

However, a subsequent CAFC decision seems to directly contradict the standard used in McKesson. In the 2009 case Exergen Corp. v. Wal-Mart Stores Inc. and S.A.A.T. Systems, [10] SAAT attempted to defend with a claim of inequitable conduct, alleging Exergen was aware of two earlier patents that it did not cite to the examiner during prosecution. The district court denied SAAT's motion for inequitable conduct as a defense, however, holding that SAAT's allegations were not specific enough to meet the particularity requirement of FRCP 9(b). The Federal Circuit Court of Appeals upheld this ruling, and ruled that such allegations must specify who engaged in inequitable conduct, what precisely that person knowingly withheld or misstated to the PTO, and how the omission or misstatement affected the patentability of individual claims. The court opined that inequitable conduct is not a "magic incantation to be asserted against every patentee" by a "mere showing that art or information having some degree of materiality was not disclosed". [9]

Therasense case

In a further development, in the 2011 case of Therasense, Inc. v. Becton, Dickinson and Co, [2] the same Federal Circuit Court of Appeals sitting en banc limited this defense to (a) occasions when patent-holders' acts are related directly to the patent, and (b) when it can be proved that patent holders engaged in deceitful intent. [11] One commentator remarked that this change has led to a "virtual alignment of inequitable conduct and Walker Process   fraud that was accomplished by Therasense." [12] Under the new standard, the Court of Appeals found no inequitable conduct in Powell v. Home Depot USA, Inc. . [13] [14]

Related Research Articles

<span class="mw-page-title-main">Patent infringement</span> Breach of the rights conferred by a patent

Patent infringement is the commission of a prohibited act with respect to a patented invention without permission from the patent holder. Permission may typically be granted in the form of a license. The definition of patent infringement may vary by jurisdiction, but it typically includes using or selling the patented invention. In many countries, a use is required to be commercial to constitute patent infringement.

In United States patent law, patent misuse is a patent holder's use of a patent to restrain trade beyond enforcing the exclusive rights that a lawfully obtained patent provides. If a court finds that a patent holder committed patent misuse, the court may rule that the patent holder has lost the right to enforce the patent. Patent misuse that restrains economic competition substantially can also violate United States antitrust law.

The exhaustion doctrine, also referred to as the first sale doctrine, is a U.S. common law patent doctrine that limits the extent to which patent holders can control an individual article of a patented product after a so-called authorized sale. Under the doctrine, once an authorized sale of a patented article occurs, the patent holder's exclusive rights to control the use and sale of that article are said to be "exhausted," and the purchaser is free to use or resell that article without further restraint from patent law. However, under the repair and reconstruction doctrine, the patent owner retains the right to exclude purchasers of the articles from making the patented invention anew, unless it is specifically authorized by the patentee to do so.

Under United States patent law a prosecution disclaimer is a statement made by a patent applicant during examination of a patent application which can limit the scope of protection provided by the resulting patent. It is one type of file-wrapper estoppel, the other being prosecution history estoppel.

<i>Mallinckrodt, Inc. v. Medipart, Inc.</i>

Mallinckrodt, Inc. v. Medipart, Inc., 976 F.2d 700, is a decision of the United States Court of Appeals for the Federal Circuit, in which the court appeared to overrule or drastically limit many years of U.S. Supreme Court precedent affirming the patent exhaustion doctrine, for example in Bauer & Cie. v. O'Donnell.

Quanta Computer, Inc. v. LG Electronics, Inc., 553 U.S. 617 (2008), is a case decided by the United States Supreme Court in which the Court reaffirmed the validity of the patent exhaustion doctrine. The decision made uncertain the continuing precedential value of a line of decisions in the Federal Circuit that had sought to limit Supreme Court exhaustion doctrine decisions to their facts and to require a so-called "rule of reason" analysis of all post-sale restrictions other than tie-ins and price fixes. In the course of restating the patent exhaustion doctrine, the Court held that it is triggered by, among other things, an authorized sale of a component when the only reasonable and intended use of the component is to engage the patent and the component substantially embodies the patented invention by embodying its essential features. The Court also overturned, in passing, that the exhaustion doctrine was limited to product claims and did not apply to method claims.

United States v. General Electric Co., 272 U.S. 476 (1926), is a decision of the United States Supreme Court holding that a patentee who has granted a single license to a competitor to manufacture the patented product may lawfully fix the price at which the licensee may sell the product.

Powell v. The Home Depot USA, Inc., 663 F.3d 1221, was a decision by the United States Court of Appeals for the Federal Circuit on the issue of patent infringement on a "safe hands" device that Michael Powell, an independent contractor for Home Depot, created in response to injuries to the hands of associates using in-store radial arm saws. Powell invented and patented a device that eliminated the risk of injury. The Home Depot refused to pay Powell for the device and began installing the safety device on its saws without permission. In 2007, Powell sued The Home Depot for patent infringement. After a jury trial in the U.S. District Court for the Southern District of Florida, Powell was awarded damages totaling $20.8 million.

TiVo Inc. v. EchoStar Corp. is a case stretching from 2004 to 2011, which took place in the United States District Court for the Eastern District of Texas and the United States Court of Appeals for the Federal Circuit. TiVo Inc. sued EchoStar Corp. claiming patent infringement of a DVR technology. The issues addressed during litigation included patent infringement, wording of injunctions, infringing product redesign, contempt of court orders, and contempt sanctions. Ultimately, the court held that EchoStar Corp. had indeed infringed TiVo Inc's patent and was in contempt of court for noncompliance of an injunction. The parties reached a settlement wherein EchoStar Corp. paid TiVo Inc. a licensing fee. Further, the court replaced the established contempt test with a single step test. The simplified test makes it more difficult for patent holders to prove contempt as a result of repeat infringement.

Medtronic, Inc. v. Mirowski Family Ventures, LLC, 571 U.S. 191 (2014), is a case of the Supreme Court of the United States that deals with civil procedure, and specifically with the question of the burden of proof required in pursuing declaratory judgments.

Morton Salt Co. v. G.S. Suppiger Co., 314 U.S. 488 (1942), is a patent misuse decision of the United States Supreme Court. It was the first case in which the Court expressly labeled as "misuse" the Motion Picture Patent/Carbice tie-in defense to a charge of patent infringement and created the present blanket remedy in infringement cases of unenforceability of the misused patent. The decision re-emphasized that misuse can be found without finding an antitrust violation.

Walker Process Equipment, Inc. v. Food Machinery & Chemical Corp., 382 U.S. 172 (1965), was a 1965 decision of the United States Supreme Court that held, for the first time, that enforcement of a fraudulently procured patent violated the antitrust laws and provided a basis for a claim of treble damages if it caused a substantial anticompetitive effect.

Akamai Technologies, Inc. v. Limelight Networks, Inc., 797 F.3d 1020, is a 2015 en banc decision of the United States Court of Appeals for the Federal Circuit, on remand from a 2014 decision of the U.S. Supreme Court reversing a previous Federal Circuit decision in the case. This is the most recent in a string of decisions in the case that concern the proper legal standard for determining patent infringement liability when multiple actors are involved in carrying out the claimed infringement of a method patent and no single accused infringer has performed all of the steps. In the 2015 remand decision, the Federal Circuit expanded the scope of vicarious liability in such cases, holding that one actor could be held liable for the acts of another actor "when an alleged infringer conditions participation in an activity or receipt of a benefit upon performance of a step or steps of a patented method and establishes the manner or timing of that performance." In addition, the court held that where multiple "actors form a joint enterprise, all can be charged with the acts of the other[s], rendering each liable for the steps performed by the other[s] as if each is a single actor."

Henry v. A.B. Dick Co., 224 U.S. 1 (1912), was a 1912 decision of the United States Supreme Court that upheld patent licensing restrictions such as tie-ins on the basis of the so-called inherency doctrine—the theory that it was the inherent right of a patent owner, because he could lawfully refuse to license his patent at all, to exercise the "lesser" right to license it on any terms and conditions he chose. In 1917, the Supreme Court overruled the A.B. Dick case in Motion Picture Patents Co. v. Universal Film Mfg. Co.,

The reverse doctrine of equivalents is a legal doctrine of United States patent law, according to which a device that appears to literally infringe a patent claim, by including elements or limitations that correspond to each element or limitation of the patent claim, nonetheless does not infringe the patent, because the accused device operates on a different principle. That is, "it performs the same or a similar function in a substantially different way." It has been said that "the purpose of the 'reverse' doctrine is to prevent unwarranted extension of the claims beyond a fair scope of the patentee's invention."

Hazel-Atlas Glass Co. v. Hartford-Empire Co., 322 U.S. 238 (1944), is a much cited 1944 decision of the United States Supreme Court dealing with fraud on the Patent Office. A widely quoted statement in the Court's opinion is: "The public welfare demands that the agencies of public justice be not so impotent that they must always be mute and helpless victims of deception and fraud." Although the fraud occurred in the late 1920s, the facts became public only much later in the Government's antitrust trial in United States v. Hartford-Empire Co.

Blonder-Tongue Labs., Inc. v. University of Ill. Foundation, 402 U.S. 313 (1971), is a decision of the United States Supreme Court holding that a final judgment in an infringement suit against a first defendant that a patent is invalid bars the patentee from relitigating the same patent against other defendants. In so ruling, the Supreme Court overruled its 1936 decision in Triplett v. Lowell, which had required mutuality of estoppel to bar such preclusion, and held that the better view was to prevent relitigating if the plaintiff had had a full and fair opportunity to litigate the issue in question.

Peter v. NantKwest Inc., 589 U.S. ___ (2019), was a United States Supreme Court case from the October 2019 term.

United States v. Throckmorton is an 1878 decision of the U.S. Supreme Court on civil procedure, specifically res judicata, in cases heard at equity. A unanimous Court affirmed an appeal of a decision by the District Court for California upholding a Mexican-era land claim, holding that collateral estoppel bars untimely motions to set aside the verdict where the purportedly fraudulent evidence has already been considered and a decision reached. In the opinion it distinguished between that kind of fraud, which it called intrinsic, and extrinsic fraud, in which deceptive actions exterior to the proceeding prevented a party, or potential party, to the action from becoming aware of the possibility they could vindicate their rights in court.

References

  1. 1 2 3 37 CFR § 1.56 (1977, revised 2012), commonly referred to as Rule 56.
  2. 1 2 3 Therasense, Inc. v. Becton, Dickinson and Co., 649 F.3d 1276 (Fed. Cir. 2011) (en banc).
  3. GS Cleantech Corp. v. Adkins Energy LLC, 951 F.3d 1310, 1324 (Fed. Cir. 2020)
  4. Keystone Driller Co. v. General Excavator Co., 290 US 240 at 243-47, 54 S.Ct. 146, 1933.
  5. United States v. Hartford-Empire Co., 46 F.Supp. 541 (N.D.Ohio 1942).
  6. Hazel-Atlas Co. v. Hartford Co., 322 U.S. 238 at 240 at 243-251, 64 S.Ct. 997, 1944.
  7. Precision Co. v. Automotive Co., 324 U.S. 806 at 807-20, 65 S.Ct. 993, 1945.
  8. "McKesson Info. Sols., Inc. v. Bridge Med., Inc., 487 F.3d 897, 902 (Fed. Cir. 2007).
  9. 1 2 Stickevers, John, Vague Allegations No Longer Acceptable When Asserting Inequitable Conduct Defense, Sunstein IP Update, 2009-08.
  10. Exergen Corp. v. Wal-Mart Stores, 575 F. 3d 1312, Ct. App. (Fed. Cir.) Aug. 2009. Nos. 2006-1491, 2007-1180.
  11. Zebley, Julia, Federal appeals court restricts inequitable conduct defense for patent law, Jurist, 2011-05-26.
  12. Gideon Mark and T. Leigh Anenson, Inequitable Conduct And Walker Process Claims After Therasense And The America Invents Act, 16 U. Pa. J. Bus. Law 361, 402 (2014).
  13. Powell v. Home Depot USA, Inc. , 663F.3d1221 ( Fed. Cir. 2011).
  14. "Post-Therasense: Inequitable Conduct Really Is a Higher Standard". McDermott Will & Emery. 2011-12-05. Retrieved 2012-09-03.

See also